Literature DB >> 30453209

Historical and clinical aspects of the 1918 H1N1 pandemic in the United States.

Barbara Jester1, Timothy M Uyeki2, Daniel B Jernigan2, Terrence M Tumpey3.   

Abstract

One hundred years have passed since the 1918 influenza pandemic caused substantial illness globally, with an estimated 50 million deaths. A number of factors, including World War I, contributed to the spread of the pandemic virus, which often caused high symptomatic attack rates and severe illness. Major achievements over the last 100 years have been made in influenza prevention, diagnosis, and treatment; however, the potential for a severe pandemic to emerge remains unchanged. We provide a review of the historical context and clinical aspects of illness due to the influenza A(H1N1) virus as it emerged and spread in 1918, with a focus on the experience in the United States. Understanding the significant social disruption and burden of illness from the 1918 pandemic can help us imagine the possible impacts of a high severity pandemic if it were to emerge now. Published by Elsevier Inc.

Entities:  

Keywords:  Epidemiology; Influenza virus; Pandemic

Mesh:

Year:  2018        PMID: 30453209     DOI: 10.1016/j.virol.2018.10.019

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Immunity Against the Omicron Variant From Vaccination, Recovery, or Both.

Authors:  Monica Gandhi
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

Review 2.  T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles.

Authors:  Luca Hensen; Patricia T Illing; Louise C Rowntree; Jane Davies; Adrian Miller; Steven Y C Tong; Jennifer R Habel; Carolien E van de Sandt; Katie L Flanagan; Anthony W Purcell; Katherine Kedzierska; E Bridie Clemens
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

3.  Déjà vu all over again: racial, ethnic and age disparities in mortality from influenza 1918-19 and COVID-19 in the United States.

Authors:  James A Koziol; Jan E Schnitzer
Journal:  Heliyon       Date:  2022-04-18

4.  The Continued Threat of Influenza A Viruses.

Authors:  Norbert J Roberts; Leonard R Krilov
Journal:  Viruses       Date:  2022-04-24       Impact factor: 5.818

5.  New endemic and pandemic pathologies with interhuman airborne transmission through ear, nose and throat anatomical sites.

Authors:  Francesco Di Gennaro; Nicola Petrosillo
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04       Impact factor: 2.618

6.  Epidemics, pandemics, and social conflict: Lessons from the past and possible scenarios for COVID-19.

Authors:  Remi Jedwab; Amjad M Khan; Jason Russ; Esha D Zaveri
Journal:  World Dev       Date:  2021-07-17

Review 7.  Clinical data to be used as a foundation to combat Covid-19 vaccine hesitancy.

Authors:  Robert G Smith
Journal:  J Interprof Educ Pract       Date:  2021-12-11

8.  Impact of 1918 influenza pandemic on mental asylums in India: An analysis of asylum reports.

Authors:  Raman Deep; Ragul Ganesh
Journal:  Indian J Psychiatry       Date:  2022-01-21       Impact factor: 1.759

Review 9.  The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era.

Authors:  Zheng Li; Yue Hu; Ming Zeng; Qinyong Hu; Fei Ye; Ruifeng Liu; Hongyi Cai; Qiang Li; Xiaohu Wang
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

10.  M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets.

Authors:  Rohan S J Ingrole; Wenqian Tao; Gaurav Joshi; Harvinder Singh Gill
Journal:  Vaccine       Date:  2021-07-21       Impact factor: 4.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.